Both in Pharmaceuticals
Alumis vs Alto Neuroscience
Over the past year ALMS returned +42.5% and ANRO returned +86.5%; their daily moves had a correlation of 0.10.
ALMS +42.5% ANRO +86.5%Growth of $1, one year, split-adjusted
| Metric | ALMS | ANRO |
|---|---|---|
| Price | $6.50 | $22.70 |
| Market cap | $841.3M | $890.8M |
| Today | +1.88% | +2.30% |
| 1 month | −5.0% | −5.5% |
| 6 months | −75.1% | −10.8% |
| Year to date | −33.4% | +27.5% |
| 1 year | +36.8% | +60.0% |
| Revenue growth (YoY) | −37.7% | — |
| Gross margin | 100.0% | — |
| Net margin | −8557.2% | — |
| P/E (TTM) | — | — |
| Price / sales | 113.7× | — |
| Net cash | $502.3M | $225.1M |
| Dividend yield | — | — |
| Volatility (60d) | 180.4% | 56.3% |
| Short % of float | 11.3% | 20.0% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).